NCT02072239View on ClinicalTrials.gov

Angioshield First-In-Human Study to Demonstrate the Preliminary Safety and Efficacy

NACompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

September 30, 2014

Study Completion Date

July 31, 2015

Conditions
Coronary Artery Disease
Interventions
DEVICE

Angioshield

The Angioshield wrap provides external structural support for the saphenous vein graft used in CABG surgery and is intended to prevent over distention of the graft under arterial pressure, potentially improving graft patency and reducing the likelihood of graft failure.

Trial Locations (1)

Unknown

Pope John Paul II Hospital, Krakow

All Listed Sponsors
lead

Neograft Technologies, Incorporated

INDUSTRY

NCT02072239 - Angioshield First-In-Human Study to Demonstrate the Preliminary Safety and Efficacy | Biotech Hunter | Biotech Hunter